Nitric Oxide (NO) Releasing Poly ADP-ribose Polymerase 1 (PARP-1) Inhibitors Targeted to Glutathione S-Transferase P1-Overexpressing Cancer Cells-Reference-Cited by-同舟云学术

Nitric Oxide (NO) Releasing Poly ADP-ribose Polymerase 1 (PARP-1) Inhibitors Targeted to Glutathione S-Transferase P1-Overexpressing Cancer Cells

Published:2014-02-25 Issue:6 Volume:57 Page:2292-2302
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Maciag Anna E.¹,Holland Ryan J.²,Kim Youseung²,Kumari Vandana³,Luthers Christina E.²,Sehareen Waheed S.²,Biswas Debanjan²,Morris Nicole L.⁴,Ji Xinhua³,Anderson Lucy M.²,Saavedra Joseph E.¹,Keefer Larry K.²

Affiliation:

1. Chemical Biology Laboratory, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland 21702, United States

2. Chemical Biology Laboratory, National Cancer Institute, Frederick, Maryland 21702, United States

3. Macromolecular Crystallography Laboratory, National Cancer Institute, Frederick, Maryland 21702, United States

4. Laboratory Animal Sciences Program, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland 21702, United States

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm401550d

Reference27 articles.

1. Safety and tolerability of the poly(ADP-ribose) polymerase (PARP) inhibitor, olaparib (AZD2281) in combination with topotecan for the treatment of patients with advanced solid tumors: a phase I study

2. A phase I study of the safety and tolerability of olaparib (AZD2281, KU0059436) and dacarbazine in patients with advanced solid tumours

3. A Phase I Combination Study of Olaparib with Cisplatin and Gemcitabine in Adults with Solid Tumors

4. Antitumor Activity of JS-K [O2-(2,4-Dinitrophenyl) 1-[(4-Ethoxycarbonyl)piperazin-1-yl]diazen-1-ium-1,2-diolate] and Related O2-Aryl Diazeniumdiolates in Vitro and in Vivo

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prudent tactics to sail the boat of PARP inhibitors as therapeutics for diverse malignancies;Expert Opinion on Drug Discovery;2023-07-31

2. Alkylation of oxytriazene oxide salts with 2-(chloromethoxy)diazene 1-oxide derivatives;Russian Chemical Bulletin;2023-07

3. Hybrid Histone Deacetylase Inhibitor: An Effective Strategy for Cancer Therapy;Current Medicinal Chemistry;2023-06

4. Novel Indole–Chalcone Derivative-Ligated Platinum(IV) Prodrugs Attenuate Cisplatin Resistance in Lung Cancer through ROS/ER Stress and Mitochondrial Dysfunction;Journal of Medicinal Chemistry;2023-03-22

5. 2D graphene oxide-l-arginine-soybean lecithin nanogenerator for synergistic photothermal and NO gas therapy;Chinese Chemical Letters;2023-03